Hosted on MSN1mon
GSK eyes up combo approval for previously withdrawn myeloma drugThe US Food and Drug Administration (FDA) has accepted a biologics license application (BLA) for Blenrep in combination with Takeda’s Velcade ... The Blenrep combo treatment could offer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback